NIKKEI 225
38,923.03 +435.13 (+1.13%) HANG SENG
18,403.04 +323.43 (+1.79%) CRUDE OIL
74.15 -2.84 (-3.69%) GOLD FUTURES
2,371.30 +25.50 (+1.09%) DOW
38,312.74 -373.58 (-0.97%) Bitcoin GBP
54,073.44 +941.36 (+1.77%)
EW Nov 2024 87.500 call
| Previous close | 7.80 |
| Open | 7.80 |
| Bid | 6.90 |
| Ask | 7.70 |
| Strike | 87.50 |
| Expiry date | 2024-11-15 |
| Day's range | 7.80 - 7.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
Investor's Business DailyEdwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.
PR NewswireBD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Edwards Lifesciences (NYSE: EW), today announced a definitive agreement under which BD will acquire Edwards' Critical Care product group ("Critical Care"), a global leader in advanced monitoring solutions, for $4.2 billion in cash, unlocking new value creation opportunities and enhancing BD's portfolio of smart connected care solutions.
Business WireEdwards Lifesciences to Sell Critical Care to BD
IRVINE, CA, June 03, 2024--Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care.
